Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZP-PTH Patch vs Forteo Pen Preference Study
NCT02478879Phase 1Completed
- Sponsor
- Zosano Pharma
- Start
- Jun 2015
- Primary completion
- Nov 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of teriparatide in osteoporosis (2 arms), sponsored by Zosano Pharma. Primary endpoint: Overall Preference at 28 days. Started Jun 2015; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT02478879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02478879.